{"id":46688,"date":"2022-07-28T16:02:22","date_gmt":"2022-07-28T14:02:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/"},"modified":"2022-07-28T16:02:22","modified_gmt":"2022-07-28T14:02:22","slug":"car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/","title":{"rendered":"CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5597299\/car-t-therapy-global-market-report-2022?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=cz8q9n&amp;utm_campaign=1732019+-+CAR-T+Therapy+Global+Market+Research+Report+2022%3A+Acute+Lymphoblastic+Leukemia%2C+Diffuse+Large+B-Cell+Lymphoma%2C+Follicular+Lymphoma%2C+Chronic+Lymphocytic+Leukemia%2C+%26+Multiple+Myeloma&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;CAR-T Therapy Global Market Report 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220728005671\/en\/1528045\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220728005671\/en\/1528045\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global CAR-T therapy market is expected to grow from $1.40 billion in 2021 to $1.80 billion in 2022 at a compound annual growth rate (CAGR) of 28.6%. The market is expected to grow to $3.55 billion in 2026 at a compound annual growth rate (CAGR) of 18.5%.\n<\/p>\n<p>\nCAR-T Therapy Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T therapy market.\n<\/p>\n<p>\nMajor players in the chimeric antigen receptor -T therapy market are Novartis AG, Kite Pharma, Pfizer Inc, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Mustang Bio, and Immune Therapeutics.\n<\/p>\n<p>\nThis report focuses on CAR-T therapy market which is experiencing strong growth. The report gives a guide to the CAR-T therapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.\n<\/p>\n<p>\nWhere is the largest and fastest growing market for the CAR-T therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The CAR-T therapy market global report answers all these questions and many more.\n<\/p>\n<p>\nThe report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market&#8217;s historic and forecast market growth by geography. It places the market within the context of the wider CAR-T therapy market, and compares it with other markets.\n<\/p>\n<ul>\n<li>\nThe market characteristics section of the report defines and explains the market\n<\/li>\n<li>\nThe market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth\n<\/li>\n<li>\nMarket segmentations break down market into sub markets\n<\/li>\n<li>\nThe regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets\n<\/li>\n<li>\nCompetitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified\n<\/li>\n<li>\nThe trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers\n<\/li>\n<li>\nThe CAR-T therapy market section of the report gives context. It compares the CAR-T therapy market with other segments of the CAR-T therapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, CAR-T therapy indicators comparison\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to Purchase<\/strong>\n<\/p>\n<ul>\n<li>\nGain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies\n<\/li>\n<li>\nUnderstand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates\n<\/li>\n<li>\nCreate regional and country strategies on the basis of local data and analysis\n<\/li>\n<li>\nIdentify growth segments for investment\n<\/li>\n<li>\nOutperform competitors using forecast data and the drivers and trends shaping the market\n<\/li>\n<li>\nUnderstand customers based on the latest market research findings\n<\/li>\n<li>\nBenchmark performance against key competitors\n<\/li>\n<li>\nUtilize the relationships between key data sets for superior strategizing\n<\/li>\n<li>\nSuitable for supporting your internal and external presentations with reliable high quality data and analysis\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>2. CAR-T Therapy Market Characteristics<\/strong>\n<\/p>\n<p>\n<strong>3. CAR-T Therapy Market Trends And Strategies<\/strong>\n<\/p>\n<p>\n<strong>4. Impact Of COVID-19 On CAR-T Therapy<\/strong>\n<\/p>\n<p>\n<strong>5. CAR-T Therapy Market Size And Growth<\/strong>\n<\/p>\n<p>\n5.1. Global CAR-T Therapy Historic Market, 2016-2021, $ Billion\n<\/p>\n<p>\n5.1.1. Drivers Of The Market\n<\/p>\n<p>\n5.1.2. Restraints On The Market\n<\/p>\n<p>\n5.2. Global CAR-T Therapy Forecast Market, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n5.2.1. Drivers Of The Market\n<\/p>\n<p>\n5.2.2. Restraints On the Market\n<\/p>\n<p>\n<strong>6. CAR-T Therapy Market Segmentation<\/strong>\n<\/p>\n<p>\n6.1. Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<ul>\n<li>\nMonotherapy\n<\/li>\n<li>\nCombination Therapy\n<\/li>\n<\/ul>\n<p>\n6.2. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<ul>\n<li>\nCD19\n<\/li>\n<li>\nCD22\n<\/li>\n<li>\nOther Target Antigen\n<\/li>\n<\/ul>\n<p>\n6.3. Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<ul>\n<li>\nAcute Lymphoblastic Leukemia\n<\/li>\n<li>\nDiffuse Large B-Cell Lymphoma\n<\/li>\n<li>\nFollicular Lymphoma\n<\/li>\n<li>\nChronic Lymphocytic Leukemia\n<\/li>\n<li>\nMultiple Myeloma\n<\/li>\n<li>\nOther Applications\n<\/li>\n<\/ul>\n<p>\n<strong>7. CAR-T Therapy Market Regional And Country Analysis<\/strong>\n<\/p>\n<p>\n7.1. Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n7.2. Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nNovartis AG\n<\/li>\n<li>\nKite Pharma\n<\/li>\n<li>\nPfizer inc.\n<\/li>\n<li>\nJuno Therapeutics\n<\/li>\n<li>\nCelgene Corporation\n<\/li>\n<li>\nCARsgen Therapeutics\n<\/li>\n<li>\nSorrento Therapeutics\n<\/li>\n<li>\nLegend Biotech\n<\/li>\n<li>\nMustang Bio\n<\/li>\n<li>\nImmune Therapeutics\n<\/li>\n<li>\nAtara Biotherapeutics\n<\/li>\n<li>\nAurora Biopharma Inc.\n<\/li>\n<li>\nEureka Therapeutics\n<\/li>\n<li>\nAutolus\n<\/li>\n<li>\nTILT Biotherapeutics\n<\/li>\n<li>\nFortress Biotech\n<\/li>\n<li>\nAutolus Therapeutics plc.\n<\/li>\n<li>\nbluebird bio\n<\/li>\n<li>\nCarina Biotech\n<\/li>\n<li>\nCARTherics\n<\/li>\n<li>\nEndocyte, Inc.\n<\/li>\n<li>\nF1 Oncology, Inc.\n<\/li>\n<li>\nFate Therapeutics Inc.\n<\/li>\n<li>\nGilead\n<\/li>\n<li>\nOxford BioMedica PLC.\n<\/li>\n<li>\nPeproMene Bio Inc.\n<\/li>\n<li>\nTessa Therapeutics Pte Ltd.\n<\/li>\n<li>\nTILT Biotherapeutics Ltd.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5597299\/car-t-therapy-global-market-report-2022?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=cz8q9n&amp;utm_campaign=1732019+-+CAR-T+Therapy+Global+Market+Research+Report+2022%3A+Acute+Lymphoblastic+Leukemia%2C+Diffuse+Large+B-Cell+Lymphoma%2C+Follicular+Lymphoma%2C+Chronic+Lymphocytic+Leukemia%2C+%26+Multiple+Myeloma&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/jjgw5z<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;&#111;&#x3a;p&#114;&#x65;s&#x73;&#x40;&#114;&#x65;s&#101;&#x61;r&#x63;&#x68;&#97;&#x6e;d&#109;&#x61;&#114;&#x6b;e&#116;&#x73;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;s&#x73;&#x40;&#x72;&#101;s&#x65;&#x61;&#x72;&#99;h&#x61;&#x6e;&#x64;&#109;a&#x72;&#x6b;&#x65;&#116;s&#x2e;&#x63;&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;CAR-T Therapy Global Market Report 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global CAR-T therapy market is expected to grow from $1.40 billion in 2021 to $1.80 billion in 2022 at a compound annual growth rate (CAGR) of 28.6%. The market is expected to grow to $3.55 billion in 2026 at &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46688","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;CAR-T Therapy Global Market Report 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global CAR-T therapy market is expected to grow from $1.40 billion in 2021 to $1.80 billion in 2022 at a compound annual growth rate (CAGR) of 28.6%. The market is expected to grow to $3.55 billion in 2026 at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-28T14:02:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220728005671\/en\/1528045\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-28T14:02:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/\"},\"wordCount\":887,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005671\\\/en\\\/1528045\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/\",\"name\":\"CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005671\\\/en\\\/1528045\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-28T14:02:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005671\\\/en\\\/1528045\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005671\\\/en\\\/1528045\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/","og_locale":"en_US","og_type":"article","og_title":"CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;CAR-T Therapy Global Market Report 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global CAR-T therapy market is expected to grow from $1.40 billion in 2021 to $1.80 billion in 2022 at a compound annual growth rate (CAGR) of 28.6%. The market is expected to grow to $3.55 billion in 2026 at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-28T14:02:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220728005671\/en\/1528045\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma &#8211; ResearchAndMarkets.com","datePublished":"2022-07-28T14:02:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/"},"wordCount":887,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220728005671\/en\/1528045\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/","url":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/","name":"CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220728005671\/en\/1528045\/21\/logo.jpg","datePublished":"2022-07-28T14:02:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220728005671\/en\/1528045\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220728005671\/en\/1528045\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/car-t-therapy-global-market-research-report-2022-acute-lymphoblastic-leukemia-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-multiple-myeloma-researchandmarket\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, &amp; Multiple Myeloma &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46688"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46688\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46688"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46688"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}